As of August 28, 2026, Iovance Biotherapeutics, Inc. (IOVA) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. Iovance Biotherapeutics, Inc. has a market capitalization of $1.83B, 452.97M shares outstanding, 289 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise
model 15%
• Under 12 months cash (9mo)
Market Data
Market Cap$1.83B
Shares Outstanding452.97M
Float387.98M
Cash$297.67M
Debt$47.78M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 18.6% shares (2026Q1 vs prior)
289 institutional holders · 325.19M shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
33.24M shares
#2
BlackRock, Inc.
31.08M shares
#3
MHR FUND MANAGEMENT LLC
28.97M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest99.98M
Days to Cover6.3
% of Float25.8%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2018-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual IOVA Dilution Snapshot
Iovance Biotherapeutics, Inc. (IOVA) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for IOVA: xbrl on 2018-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track IOVA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IOVA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for IOVA
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.